A randomized Phase 2 study to compare erlotinib with or without bevacizumab in previously untreated patients with advanced non–small cell lung cancer with EGFR mutation
Journal article published in 2022 by
Youngjoo Lee 
,
Hye Ryun Kim,
Min Hee Hong ,
Ki Hyeong Lee,
Keon Uk Park ,
Geon Kook Lee,
Hyae Young Kim,
Soo‐Hyun Lee,
Kun Young Lim,
Sung Jin Yoon,
Byoung Chul Cho ,
Ji‐Youn Han
,
Hye Ryun Kim,
Min Hee Hong ,
Ki Hyeong Lee,
Keon Uk Park ,
Geon Kook Lee,
Hyae Young Kim,
Soo‐Hyun Lee,
Kun Young Lim,
Sung Jin Yoon,
Byoung Chul Cho ,
Ji‐Youn Han
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 